Home / Markets / News / Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

The company reported a net profit of Rs 301 crore in Q1FY21, against Rs 124 crore in the year-ago quarter.

pharmacy, drugs, medicine, pharma companies, pharmaceuticals, vaccine, coronavirus, covid, testing

Premium

According to virologists, there are four phases to developing a vaccine.

2 min read Last Updated : Jul 22 2020 | 2:35 PM IST

Shares of Alembic Pharmaceuticals hit a new high of Rs 1,044, up 5 per cent on the BSE on Wednesday after the company's profit more-than-doubled to Rs 301 crore in June quarter (Q1FY21), on the back of strong revenue growth in the US. The pharmaceutical company had a profit of Rs 124 crore in the year-ago quarter.

The company's net sales grew 41 per cent at Rs 1,341 crore against Rs 949 crore in the corresponding quarter of the previous fiscal. EBITDA (earnings before interest, taxes, depreciation, and amortisation) rose 108 per cent to Rs 416 crore, while margins improved to

Topics : Alembic Pharmaceuticals Buzzing stocks Markets Sensex Nifty Q1 results

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in